BMO Capital Upgrades National Health Investors to Outperform, Announces $67 Price Target
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst John Kim upgraded National Health Investors (NYSE:NHI) from Market Perform to Outperform with a new price target of $67.
March 12, 2024 | 11:33 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
National Health Investors was upgraded by BMO Capital from Market Perform to Outperform with a price target of $67.
Upgrades by reputable analysts like John Kim from BMO Capital typically lead to positive short-term price movements. The upgrade from Market Perform to Outperform suggests a strong confidence in the company's future performance, and the setting of a $67 price target indicates a bullish outlook on the stock's value.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100